Trial
NCT01839526
A Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry Disease
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Genzyme, a Sanofi Company
Collaborators
—
Condition
Fabry Disease
Intervention
Iohexol
Why stopped
Enrollment period not extended and screening stopped for slow recruitment and in accordance with provisions of the protocol. Not linked to any safety concern
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-12-16